These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 21569770)
1. IDH1 mutations in gliomas: first series from a tertiary care centre in India with comprehensive review of literature. Jha P; Suri V; Sharma V; Singh G; Sharma MC; Pathak P; Chosdol K; Jha P; Suri A; Mahapatra AK; Kale SS; Sarkar C Exp Mol Pathol; 2011 Aug; 91(1):385-93. PubMed ID: 21569770 [TBL] [Abstract][Full Text] [Related]
2. Segregation of non-p.R132H mutations in IDH1 in distinct molecular subtypes of glioma. Gravendeel LA; Kloosterhof NK; Bralten LB; van Marion R; Dubbink HJ; Dinjens W; Bleeker FE; Hoogenraad CC; Michiels E; Kros JM; van den Bent M; Smitt PA; French PJ Hum Mutat; 2010 Mar; 31(3):E1186-99. PubMed ID: 20077503 [TBL] [Abstract][Full Text] [Related]
4. Detection of IDH1 mutations in gliomatosis cerebri, but only in tumors with additional solid component: evidence for molecular subtypes. Seiz M; Tuettenberg J; Meyer J; Essig M; Schmieder K; Mawrin C; von Deimling A; Hartmann C Acta Neuropathol; 2010 Aug; 120(2):261-7. PubMed ID: 20514489 [TBL] [Abstract][Full Text] [Related]
5. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas. Hartmann C; Meyer J; Balss J; Capper D; Mueller W; Christians A; Felsberg J; Wolter M; Mawrin C; Wick W; Weller M; Herold-Mende C; Unterberg A; Jeuken JW; Wesseling P; Reifenberger G; von Deimling A Acta Neuropathol; 2009 Oct; 118(4):469-74. PubMed ID: 19554337 [TBL] [Abstract][Full Text] [Related]
6. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179 [TBL] [Abstract][Full Text] [Related]
7. Single-copy gain of chromosome 1q is a negative prognostic marker in pediatric nonependymal, nonpilocytic gliomas. Miwa T; Hirose Y; Sasaki H; Ezaki T; Yoshida K; Kawase T Neurosurgery; 2011 Jan; 68(1):206-12. PubMed ID: 21099717 [TBL] [Abstract][Full Text] [Related]
8. Losses of chromosomal arms 1p and 19q in the diagnosis of oligodendroglioma. A study of paraffin-embedded sections. Burger PC; Minn AY; Smith JS; Borell TJ; Jedlicka AE; Huntley BK; Goldthwaite PT; Jenkins RB; Feuerstein BG Mod Pathol; 2001 Sep; 14(9):842-53. PubMed ID: 11557779 [TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity analysis in malignant gliomas. Mizoguchi M; Kuga D; Guan Y; Hata N; Nakamizo A; Yoshimoto K; Sasaki T Brain Tumor Pathol; 2011 Jul; 28(3):191-6. PubMed ID: 21629980 [TBL] [Abstract][Full Text] [Related]
10. Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma. Raghunathan A; Olar A; Vogel H; Parker JR; Coventry SC; Debski R; Albarracin CT; Aldape KD; Cahill DP; Powell SZ; Fuller GN Ann Diagn Pathol; 2012 Aug; 16(4):255-9. PubMed ID: 22445362 [TBL] [Abstract][Full Text] [Related]
11. [Feature analysis of IDH1 mutation in oligodendroglial tumors]. Ren XH; Cui XL; Shang ZM; Lin S Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(11):724-6. PubMed ID: 22781348 [TBL] [Abstract][Full Text] [Related]
12. Alterations of the TP53 gene in human gliomas. Rasheed BK; McLendon RE; Herndon JE; Friedman HS; Friedman AH; Bigner DD; Bigner SH Cancer Res; 1994 Mar; 54(5):1324-30. PubMed ID: 8118823 [TBL] [Abstract][Full Text] [Related]
13. Expression of p53 and prognosis in children with malignant gliomas. Pollack IF; Finkelstein SD; Woods J; Burnham J; Holmes EJ; Hamilton RL; Yates AJ; Boyett JM; Finlay JL; Sposto R; N Engl J Med; 2002 Feb; 346(6):420-7. PubMed ID: 11832530 [TBL] [Abstract][Full Text] [Related]
14. PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Rasheed BK; Stenzel TT; McLendon RE; Parsons R; Friedman AH; Friedman HS; Bigner DD; Bigner SH Cancer Res; 1997 Oct; 57(19):4187-90. PubMed ID: 9331072 [TBL] [Abstract][Full Text] [Related]
15. IDH1 mutation in pediatric gliomas: has it a diagnostic and prognostic value? Buccoliero AM; Castiglione F; Degl'Innocenti DR; Gheri CF; Genitori L; Taddei GL Fetal Pediatr Pathol; 2012 Oct; 31(5):278-82. PubMed ID: 22432788 [TBL] [Abstract][Full Text] [Related]
16. IDH2 mutations are commonly associated with 1p/19q codeletion in diffuse adult gliomas. Appay R; Tabouret E; Macagno N; Touat M; Carpentier C; Colin C; Ducray F; Idbaih A; Mokhtari K; Uro-Coste E; Dehais C; Figarella-Branger D; Neuro Oncol; 2018 Apr; 20(5):716-718. PubMed ID: 29522183 [No Abstract] [Full Text] [Related]
17. Genomic profiling of lower-grade gliomas uncovers cohesive disease groups: implications for diagnosis and treatment. Zhang CM; Brat DJ Chin J Cancer; 2016 Jan; 35():12. PubMed ID: 26758195 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of IDH1 in gliomas: a tissue microarray-based approach. Sipayya V; Sharma I; Sharma KC; Singh A J Cancer Res Ther; 2012; 8(4):598-601. PubMed ID: 23361281 [TBL] [Abstract][Full Text] [Related]
19. Repeated molecular testing in gliomas: a retrospective study of 53 cases. Mahajan D; Prayson RA Am J Clin Pathol; 2009 Jul; 132(1):118-24. PubMed ID: 19864242 [TBL] [Abstract][Full Text] [Related]
20. Analysis of the IDH1 codon 132 mutation in brain tumors. Balss J; Meyer J; Mueller W; Korshunov A; Hartmann C; von Deimling A Acta Neuropathol; 2008 Dec; 116(6):597-602. PubMed ID: 18985363 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]